[1]
Abed, A. and Fezea, A. 2026. Serum interleukin-6 as an inflammatory biomarker in type 2 diabetes mellitus: correlation with diabetic peripheral neuropathy and diagnostic performance. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 33, 3 (Sep. 2026), 365-372.